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ABSTRACT 
Many infectious diseases can lead to re-infection. We examined the relationship between the 
prevalence of repeat infection and the basic reproductive number (R0). First we solved a generic, 
deterministic compartmental model of re-infection to derive an analytic solution for the 
relationship. We then numerically solved a disease specific model of syphilis transmission that 
explicitly tracked re-infection. We derived a generic expression that reflects a non-linear and 
monotonically increasing relationship between proportion re-infection and R0 and which is 
attenuated by entry/exit rates and recovery (i.e. treatment). Numerical simulations from the 
syphilis model aligned with the analytic relationship. Re-infection proportions could be used to 
understand how far regions are from epidemic control, and should be included as a routine 
indicator in infectious disease surveillance. 
 
Keywords: Re-infection; basic reproductive number; compartmental model; syphilis; dynamical 
system  
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ABBREVIATIONS 
S-I-S susceptible-infectious-susceptible 
S-I-R susceptible-infectious-recovered 
S-E-I-R-S susceptible-exposed-infectious-recovered-susceptible 
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1. INTRODUCTION 
 
Infectious disease surveillance systems use observed data to gauge epidemic spread, persistence, 
and control (Wolicki et al., 2016). Most surveillance relies on per-capita rates of diagnosed cases 
to characterize disease persistence, with or without the help of disease transmission models 
(Bansal, Chowell, Simonsen, Vespignani, & Viboud, 2016). Many infectious diseases can be 
acquired more than once and transmission models that explicitly capture re-infection 
demonstrate their influence on peak incidence (Barros & Pinho, 2017; Brewer, Peterman, 
Newman, & Schmitt, 2011; Martinello et al., 2017; Mutsaka-Makuvaza et al., 2018). However, 
what remains unknown is whether and how observed cases of re-infections could help 
characterize how far a locale may be from epidemic control (Barros & Pinho, 2017). 
 
Re-supply of susceptible individuals is important in the persistence of infectious disease 
transmission and the loss of herd immunity. The replenishing of the susceptible population 
through treatment, and consequent re-infection, is of particular interest in the study of syphilis 
epidemics. Rates of syphilis continue to rise across the globe and particularly in industrialized 
settings, where the proportions of new diagnoses that represent re-infection are also increasing 
(Fenton et al., 2008; Shakeri A, 2017). As a result, syphilis screening and other interventions are 
now being directed towards those with a history of documented syphilis to prevent re-infection at 
the individual-level, and incidence at the population-level (Lapple, Wylie, Ross, & Plourde, 
2017). 
 
Re-infection is a part of the natural history of many infectious diseases, with or without 
treatment. For example, infections naturally cleared by the host without conferring protective 
immunity are often abstracted as “S-I-S” (susceptible-infectious-susceptible) systems leading to 
cycles of infection and re-infection (Anderson & May, 1991). When infections confer a 
protective immunity that is aborted by treatment – we shift systems from “S-I-R” (susceptible-
infectious-recovered) to “S-I-R-S” (Anderson & May, 1991). 
 
Syphilis is a sexually transmitted infection whose natural history without treatment follows an 
“S-E-I-R-S” system, with a short exposed (E) period following inoculation and before 
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infectiousness. Treatment aborts the transition from infectiousness during early syphilis to a 
‘recovered’ or clinically latent phase, wherein the pathogen (T.pallidum) remains in the body but 
cannot be transmitted to a sexual partner. Debate surrounds the duration of waning immunity 
following treatment in the “recovered” or latent phase of syphilis. While many epidemic models 
of syphilis use an average of 1 to 10 years of a waning or partial immunity following treatment 
of the latent stage (Gray et al., 2010; Pourbohloul, Rekart, & Brunham, 2003; Tuite & Fisman, 
2016), empirical data on how fast protective immunity is lost remain scarce (Magnuson et al., 
1956). What is known, however, is that clinical cases of re-infection have been documented 
following treatment at all stages of syphilis (Ogilvie et al., 2009; Shakeri A, 2017).   
 
Models of syphilis interventions suggest that a prioritized approach to those with a history of 
treated infection could be more efficient at reducing transmission, compared with applying the 
same intervention to all susceptible persons (Tuite A, 2017). These findings hint at re-infection 
as a marker of epidemic emergence and persistence – and raise questions about whether the 
proportion re-infection could tell us about how far we are from epidemic control. We therefore 
sought to determine if the proportion re-infection could be used to characterize the underlying 
transmission dynamics, specifically the basic reproductive number R0 of epidemics with re-
infection like that of syphilis. 
  
2. METHODS 
 
Our investigation into the relationship between proportion re-infection and R0 included two 
components. We conducted a theoretical analysis of a generic ‘S-I-S’ system with re-infection 
followed by numerical simulations of a more complex model to capture the natural history of 
untreated and treated syphilis. Both models were compartmental deterministic systems of 
coupled differential equations. 
 
2.1 Generic re-infection model 
We expanded the standard ‘S-I-S’ model by separating initial and repeat infections into four 
states: S1, I1, S2, and I2 (Figure 1a). The open population was homogeneous and remained stable 
with balanced births and deaths. Individuals entered the population (for example, at the onset of 
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sexual activity) as S1, move into compartment I1 during their first infection, and then recover (for 
example via treatment) into S2  - and then remain within the ‘S2-I2-S2’ cycle following re-
infection (I2) and treatment.  
 
 
Figure 1: Model schematic for the (a) generic and (b) disease specific models of re-
infection. Each compartment represents a health state. The parameters describing the rate of 
transition between compartments of the disease specific model (b) are defined in Table 1. Force 
of infection 𝜆𝑖 is defined in Appendix. Parameters in the generic model are used only for 
theoretical analysis and are not assigned specific numerical values. The disease specific model 
reflects a simplified biology of syphilis infection and re-infection. 
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Table 1. Parameters for the disease specific model of syphilis. 
Parameter Symbol Unit 
Default value 
or range used 
in sampling  
Source 
Population characteristics 
Population Size 𝑁   366 279 
Combined from adult ( aged 15-
64) male population in 
Canada(Statistics Canada, 2018b) 
(12 209 300) and estimated 
proportion of adult males who 
report sex with other men 
(0.03)(Statistics Canada, 2015) 
Rate of entry into 
the modeled 
population  
𝜇𝑁 
Person/
Year 
5 831 
Population growth based on birth 
rate of males(Statistics Canada, 
2018a) applied to proportion who 
have sex with other men 
Syphilis natural history  
Transmission 
probability per sex 
act 
𝛽   
Uniform 
(0.09, 0.64) 
(Alexander & Schoch, 1949; 
Garnett, Aral, Hoyle, Cates, & 
Anderson, 1997; Moore, Price, 
Knox, & Elgin, 1963) 
Incubation period 1/𝛼  Days 25 (Garnett et al., 1997) 
Infectious period 1/𝜌 Days 154 
(Garnett et al., 1997) 
Protective 
immunity period 
1/𝜎 Years 5 
(Garnett et al., 1997) 
Public health characteristics 
Per-capita 
treatment rate (per 
year) 
 
 
Uniform 
(0.1, 0.8) 
 (Remis RS et al., 2010 ) 
Partnership characteristics 
Average number of 
partnerships per 
year (per-capita 
partner change 
rate) 
𝑐𝑎𝑣𝑔 Person 15 
Generated from survey data - 
Lambda survey: M-Track Ontario 
second generation surveillance 
(2010)(Remis RS et al., 2010 ).  
In the model (Appendix), cH refers 
to partner change rate in the high-
activity group, and cL in the low-
activity group. The weighted 
average results in the default 
value of 𝑐𝑎𝑣𝑔. 
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Proportion of 
individuals in the 
high activity group 
𝑁𝐻/𝑁   
Uniform 
(0.079, 0.217) 
Lower bound: Lambda, Upper 
bound: M-Track Ontario second 
generation surveillance 
(2010)(Remis RS et al., 2010 ) 
Ratio of high to 
low activity 
partnership 
numbers 
𝑐𝐻/𝑐𝐿   
Uniform 
(5, 10) 
Assumption 
 
The differential equations are as follows: 
𝑑𝑆1
𝑑𝑡
= 𝜇𝑁 − 𝛽(𝐼1 + 𝐼2)𝑆1 − 𝜇𝑆1         (1) 
𝑑𝐼1
𝑑𝑡
= 𝛽(𝐼1 + 𝐼2)𝑆1 −  𝜌𝐼1 − 𝜇𝐼1         (2) 
𝑑𝑆2
𝑑𝑡
= 𝜌(𝐼1 + 𝐼2) − 𝛽(𝐼1 + 𝐼2)𝑆2 − 𝜇𝑆2        (3) 
𝑑𝐼2
𝑑𝑡
= 𝛽(𝐼1 + 𝐼2)𝑆2 −  𝜌𝐼2 − 𝜇𝐼2         (4) 
 
where 𝜇 is the entry and exit rate, N is the population, 𝛽 represents the probability of 
transmission, and 𝜌 is the per capita rate of treatment applied at the same value to the first (I1) or 
a repeat infection (I2). 
 
The Appendix details the derivation of an explicit relationship between R0 and the prevalence of 
re-infection, defined as I2/(I1+I2). We set the right-hand-side of the differential equations to 0 to 
identify the disease-free and endemic equilibria. Following van den Driessche and Watmough, 
we derived an expression for R0.(Pauline van den Driessche, 2017; P. van den Driessche & 
Watmough, 2002) Then by expressing the endemic equilibrium in terms of R0, we derived the 
relationship between R0 and the prevalence of re-infection. Finally, we studied the local stability 
of this fixed point.  
 
2.2 Disease specific syphilis model 
To complement our theoretical analysis, we performed numerical simulations of the sexual 
transmission of syphilis to illustrate the range of observed epidemics among gay, bisexual, and 
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other men who have sex with men (MSM) across Canada (Choudhri Y, Miller J, Sandhu J, Leon 
A, & J, 2018; Public Health Agency of Canada, 2017). The model is detailed in the Appendix. 
 
We included the following compartments to represent a simplified version of the natural history 
of syphilis (Figure 1b, Table 1):(Garnett et al., 1997) susceptible (S1, S2), exposed (E1, E2), 
infectious syphilis (I1, I2), and latent (non-infectious) syphilis (L1, L2). As with the generic re-
infection model, we stratified the system into first time and repeat infections. Based on the 
current understanding of the natural history following treatment, we assumed that individuals 
treated in the I1 compartment became immediately susceptible to future infections (i.e. moved 
into S2). However, treatment while in the latent stage meant that individuals experienced a period 
of waning immunity before becoming susceptible to re-infection.  
 
We included heterogeneity in risk via two sexual activity-levels (𝑐𝐻 [high-activity], and 𝑐𝐿 [low-
activity]), and assumed proportionate mixing when partnerships were formed (Garnett & 
Anderson, 1994). The population size stayed constant and individuals remained within their 
activity groups.  
 
To examine the relationship between proportion re-infection and R0, we generated 4900 
synthetic epidemics at equilibrium within the observed rates of annual diagnoses of infectious 
syphilis among MSM in urban centers across Canada (<1100 cases per 100 000 MSM) 
(Choudhri Y et al., 2018; Public Health Agency of Canada, 2017). We used biological and 
sexual behaviour data from the literature to parameterize the model (Table 1). We drew 
parameters from surveys of the MSM community across Canada, Canadian demographic data, 
and reviews of the biological properties of syphilis. To generate the synthetic epidemics, we used 
latin hypercube sampling across the following parameters assuming uniform distributions: 
biological probability of transmission per partnership (𝛽); proportion of individuals in the high 
activity group (NH/N), the ratio of partner change rate among the high and low activity groups 
(𝑐𝐻/𝑐𝐿); and the treatment rate (). To derive R0, we calculated the next generation matrix to find 
the dominant eigenvalue (Appendix) (Pauline van den Driessche, 2017; P. van den Driessche & 
Watmough, 2002).  
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3. RESULTS 
 
3.1 Generic model 
From our analysis of the next generation matrix, R0 for the generic model is equivalent to the 
standard SIS model with 𝑅0 =
𝛽
𝜌+𝜇
. Using the fact that a standard SIS model has an endemic 
equilibrium at (𝑆∗, 𝐼∗) = (
1
𝑅0
, 1 −
1
𝑅0
), we found that our general model has unique disease-free 
and endemic equilibria at  
(𝑆1
∗∗, 𝐼1
∗∗, 𝑆2
∗∗, 𝐼2
∗∗) = (𝑁, 0,0,0) and (𝑆1
∗, 𝐼1
∗, 𝑆2
∗, 𝐼2
∗) = (𝑆∗(1 − 𝜅), 𝐼∗(1 − 𝜅), 𝑆∗𝜅, 𝐼∗𝜅) (4) 
and where,  
𝜅 =
𝑅0+1
𝑅0+1+
𝜇
𝜌
𝑅0
.           (5) 
This means that at the endemic equilibrium, the proportion re-infection is 
𝐼2
∗
𝐼∗
= 𝜅 =  
𝑅0+1
𝑅0+1+
𝜇
𝜌
𝑅0
.           (6) 
 
By analyzing the local stability of the two equilibria, we find that when 𝑅0>1, the disease free 
fixed point is unstable and the endemic fixed point is stable. The opposite is the case when 𝑅0<1.  
 
Equation (6) indicates that R0 increases with proportion re-infection via a non-linear monotonic 
relationship. Each incremental increase in the proportion re-infection indicates a larger and larger 
increase in R0. The non-linear relationship is illustrated in Figure 2 under varying treatment rates 
(ρ) and assuming fixed exit rate (). The relationship is modified by the ratio of treatment and 
exit rates: a lower proportion re-infection may signal a large R0 when the baseline treatment rates 
are low (Figure 2) or when exit rates (such as turn-over in the high-activity population) are high. 
 
11 
 
 
Fig. 2: Analytic relationship between proportion re-infection and R0, stratified by 
treatment rate. Results are based on the generic model. 
 
3.2 Disease specific syphilis model 
The R0 of the syphilis model is given by (Appendix): 
𝑅0 =
αβ(cH gH+cL gL)
(α+μ)(ρ+τ+μ)
          (7) 
 
Figure 3 depicts R0 for each modeled proportion re-infection from the synthetic epidemics 
stratified by the annual diagnoses of syphilis. The non-linear convex relationship between the 
proportion re-infection and R0 is similar to that derived from the generic model (Figure 2).  
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Fig. 3: Simulations of the relationship between proportion re-infection and R0 by rate of 
diagnoses. Results are based on the disease-specific model. Diagnoses rates reflect cases per 
100,000 individuals.  
 
For a given R0, higher proportion re-infection and larger annual diagnoses cluster together 
(Figure 3). Figure 3 also demonstrates that for a given proportion re-infection (for example, 
60%), R0 is larger with smaller “observed” epidemics (that is, epidemics with fewer annual 
diagnoses per 100,000 MSM). The reason for this is depicted in Figure 4. Most of the smaller 
“observed” epidemics (annual diagnoses, 400-600 per 100,000 MSM) are constrained to very 
low treatment rates. In contrast, most of the larger “observed” epidemics (annual diagnoses, 800-
1100 per 100,000 MSM) are constrained to medium/high treatment rates. The treatment rate also 
effects how sharply R0 increases with proportion re-infection (Figure 4). Low treatment rates are 
associated with a steeper increase in R0 per increase in proportion re-infection.  
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Fig. 4: Simulations of the relationship between proportion re-infection and R0 stratified by 
treatment rates. Results are based on the disease-specific model. Diagnoses rates reflect cases 
per 100,000 individuals. 
 
 
4. DISCUSSION 
 
These results have two key implications for surveillance of infectious diseases where repeat 
infections are possible. First, the proportion re-infection can be used to infer how far a 
population is from epidemic control in a given setting. Settings with smaller proportion re-
infection would be closer to epidemic control, and vice versa.  Due to the non-linearity of the 
relationship between these two quantities, the effect of reductions or increases in the proportion 
re-infection on R0 is particularly dramatic when the proportion re-infection is high. For example, 
if we assume similar rates of syphilis treatment in two Canadian cities – the epidemic is harder to 
control in the city with the higher proportion re-infection. Although we did not perform any 
counterfactuals, this relationship would be consistent with other studies that suggest prioritizing 
interventions for those infected at least once could be an efficient control strategy (Tuite A, 
2017). 
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The second implication for disease surveillance is the unexpected relationship between rates of 
observed cases and R0. Our synthetic epidemics clustered such that for a given proportion re-
infection, lower rates of diagnosed syphilis were associated with a higher R0. Variations in 
treatment explain this counterintuitive finding. Since the rate of new diagnoses is a function of 
both the true incidence and the treatment rate, a low observed incidence could stem from either 
low incidence or low case detection rates. The epidemics with few observed cases and a high R0 
also are those with a low treatment rate, which means many infections remain undiagnosed. The 
result is that observed cases are a large underrepresentation of true incidence. Conversely, when 
treatment rates are high, the observed diagnoses rates more accurately reflect the true incidence, 
leading to a positive correlation between observed cases and R0. Increased treatment also reduces 
R0 by shortening the duration of infectiousness. Taken together, this means that observed 
diagnosis rates, due to a dependence on both the true incidence and the treatment rate, is an 
unreliable proxy for R0 and should not be used alone to assess how far a given setting is from 
epidemic control. While the difference between observed versus true incidence is well-
established and its implications discussed (Rothman, Greenland, & Lash, 2008), especially in the 
context of increased testing over time (Miller, 2008), the use of observed cases to directly or 
inadvertently infer epidemic potential in the public health literature remains (National 
Collaborating Centre for Infectious Diseases, 2017; Public Health Agency of Canada, 2017). Our 
findings provide further evidence that when comparing observed per-capita syphilis rates 
between two cities, the city with the seemingly larger epidemic may not be the one with the more 
difficult to control epidemic.  
 
Under the assumption that the treatment rate is the same for new and repeat infections, 
measuring proportion re-infection bypasses the challenges associated with using observed 
diagnoses to infer R0. Treatment rates affect the numerator and denominator of the proportion re-
infection equally, meaning the observed proportion re-infection is equivalent to the true 
proportion re-infection given our assumptions. Analyzing the proportion re-infection could give 
a more accurate picture of the epidemic than the rate of new diagnoses, leading to a better 
understanding of R0. In fact, using the proportion re-infection and the observed diagnoses 
together gives the best estimate of R0. Our analytical relationship between R0 and the proportion 
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re-infection is stratified by the treatment rate. Since the observed diagnoses and the proportion 
re-infection also uniquely determine the treatment rate, stratifying our results by the observed 
diagnoses could thus narrow the inference on R0. 
 
Interpretation of the findings is limited to the analytic and illustrative case study of syphilis 
transmission. The findings surrounding inference using proportion re-infection do not account 
for stochasticity - which are particularly important when considering smaller population size 
(Anderson & May, 1991); nor plausible differences in testing and treatment rates among those 
with a prior history of infection versus those without (Workowski & Berman, 2006). We also did 
not study the implications on trends in proportion re-infection over time and its relation to the 
effective reproductive number. Although findings can be expected to be similar given the 
relationship between the basic and effective reproductive numbers (Anderson & May, 1991; 
Pauline van den Driessche, 2017), future work involves examining the utility of monitoring 
proportion re-infection alongside trends in observed cases to evaluate the impact of control 
strategies over time. 
 
5. CONCLUSION 
 
Using generic and disease-specific mathematical models that captured re-infection, we identified 
a relationship between proportion re-infection and R0. We derived a generic expression that 
reflects a non-linear and monotonically increasing relationship between proportion re-infection 
and R0 and which is attenuated by entry/exit rates and recovery (i.e. treatment). Our findings 
highlight the potential for systematically reporting and using data on re-infection alongside 
observed diagnoses as part of disease surveillance for any pathogen that can cause repeat 
infections. In doing so, public health teams could gain a better understanding of the underlying 
disease dynamics, allowing them to identify settings and populations where more resources may 
be required to achieve local epidemic control.  
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